We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Tissue Regenix CFO joins board

Fri 17 October 2025 12:06 | A A A

No recommendation

No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.

(Sharecast News) - Tissue Regenix announced on Friday that its chief financial officer Kirsten Lund had joined the company's board with immediate effect.

The AIM-traded regenerative medical devices group confirmed the appointment following its earlier announcement on 16 October.

Lund, 41, owns 113,557 company shares.

At 1235 BST, shares in Tissue Regenix Group were down 9.67% at 8.13p.

Reporting by Josh White for Sharecast.com.

    The value of investments can go down in value as well as up, so you could get back less than you invest. It is therefore important that you understand the risks and commitments. This website is not personal advice based on your circumstances. So you can make informed decisions for yourself we aim to provide you with the best information, best service and best prices. If you are unsure about the suitability of an investment please contact us for advice.


    More AIM news from ShareCast

    No results were found